Obici Healthcare Foundation

Obici Healthcare Foundation

The Obici Healthcare Foundation was established in 2006, converting the legacy of Planters Peanuts founder Amedeo Obici into a permanent grantmaking institution. Unlike a healthcare system or a family office, its formation was a direct result of Sentara Healthcare's acquisition of the Louise Obici Memorial Hospital. That transaction spun the family's charitable intent into an independent foundation now focused on the medically indigent and uninsured in Suffolk and the surrounding Western Tidewater region. In terms of strategy, the foundation operates as a private, independent entity with a portfolio spanning buyout, co-investment, early-stage, growth, and venture debt allocations — an unusually broad set for a mission-driven funder of this size. Its balance sheet, estimated by Altss at roughly $143 million, is managed to sustain recurring grant cycles while participating in special situations and natural resources. The geographic mandate is tightly bound to Western Tidewater, Virginia, with programmatic commitments to local community health collaboratives including the Center for Nonprofit Excellence. The office is led by President and CEO R. Battle Betts, Jr. and maintains professional ties to the Virginia Funders Network, Southeastern Council of Foundations, Council on Foundations, and Exponent Philanthropy. The foundation's footprint is concentrated at its Finney Avenue headquarters in Suffolk. In day-to-day operations, it blends grantmaking with capacity building for regional nonprofits, while George Y. Birdsong of Birdsong Peanuts remains a board emeritus tie to the Obici family's original business circle. What distinguishes the Obici Healthcare Foundation structurally is its unusual origin and investment posture. It behaves as neither a community foundation nor a donor-advised fund sponsor but as an independent endowment shaped by a hospital-sale covenant. This architecture separates it from the healthcare delivery system entirely and directs all returns toward public-health outcomes — making its capital stack effectively a single-mission liability managed on an asset-owner's timeline. The investment menu, which extends to venture debt and special situations, signals a board-level appetite for uncorrelated returns to fund the grant-making base.